Cognuse Neuroscience

Executive Summary

Cognuse Neuroscience is a San Francisco-based digital health company founded in 2020 that offers a comprehensive software platform for patient rehabilitation and critical disease management across the care continuum. The platform integrates guideline adherence, interactive therapy exercises, patient education, and remote monitoring, empowering clinicians, caregivers, and families to improve recovery from acute hospital settings to outpatient and chronic care. By addressing fragmentation in rehabilitation and disease management, Cognuse aims to enhance outcomes while reducing costs. The company operates in the growing digital health and neuroscience sectors but remains private with no disclosed funding or valuation. Its success will depend on adoption by healthcare providers and evidence of clinical efficacy.

Upcoming Catalysts (preview)

• Q3 2026Partnership with a Major Hospital System or ACO60% success
• Q4 2026Launch of AI-Enhanced Rehabilitation Module50% success
• Q2 2026Publication of Real-World Evidence Study on Clinical Outcomes40% success